Oral Genome , a leader in oral and systemic health innovation and known for its rapid Oral Health Saliva Test, has been named a finalist in the prestigious 2025 Pepperdine Graziadio Most Fundable Companies competition. Out of more than 2,300 early stage startups from across the US, Oral Genome is among the top 26 companies recognized for its market opportunity, innovation, and leadership.

Now in its 8th year, Pepperdine’s Most Fundable Companies program identifies startups that demonstrate exceptional promise and investor readiness. Finalists were selected based on rigorous evaluation of financial projections, intellectual property, competitive advantage, and management expertise.

“This recognition affirms Oral Genome’s mission to make preventive oral and whole-body health testing ac

See Full Page